Mariela Martinez-Rivera, MD
Payments from drug & device makers
What this record shows
This record is dominated by grants: $100,000 of the $104,892 with a category attached, or 95.3%. Boston Scientific accounts for 98.2% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $101,265, more than ten times the $106 reported in 2023. Among urology clinicians in PR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 52 payments — averaging $2017.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$103K
- Coloplast$2K
- AstraZeneca$228
- Johnson & Johnson$81
- BD$25
- PBG Puerto Rico LLC$19
- plus $36 from 2 others
What the payments were for
- Grants$100,00095%
- Travel & lodging$2,7483%
- Food & beverage$1,8772%
- Education$2680%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 25 | $102,976 |
| Coloplast | 11 | $1,527 |
| AstraZeneca | 10 | $228 |
| Johnson & Johnson | 2 | $81 |
| BD | 1 | $25 |
| PBG Puerto Rico LLC | 1 | $19 |
| Atricure, Inc. | 1 | $19 |
| Medtronic | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL ERECTILE DYSFUNCTION$50,359
- GENERAL - THERAPIES$50,000
- TITAN$1,354
- TACTRA$247
- AMS 700$153
How this compares
$104,892 in reported general payments places this provider in the 95th percentile of 122 urology providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 14 | $136 |
| Tamsulosin Hcl | 11 | $51 |
Paid to pharmacies, not to this prescriber.
Other urology in Ponce
- Claudio Bernaschina BobadillaPonce$132K
- Javier CastilloPonce$41K
- Gilberto Ruiz DeyaPonce$32K
- Giovanni Gonzalez AlboPonce$13K
- Richard Baez TelladoPonce$10K
- Rafael BritoPonce$4K
- Jan VazquezPonce$3K
- Felix Mendoza RosaPonce$3K
- Adrian Santana ParacchiniPonce$2K
- Freddy Mendez TorresCayey$95K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.